The use of phosphate‐affinity SDS‐PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
We have used phosphate affinity SDS‐PAGE to separate the phosphorylated species of cardiac troponin I (cTnI). To test the method we phosphorylated pure cTnI with protein kinase A catalytic subunit and observed up to six bands corresponding to 0, 1P, 2P, 3P, 4P and 5P phospho‐species. We examined the phospho‐species of cTnI in human heart myofibrillar extracts by phosphate affinity SDS‐PAGE and Western blotting with a non‐specific troponin I (TnI) antibody. In donor heart samples the bis‐phosphorylated species of cTnI predominated and no more highly phosphorylated species were not detectable (0P was 10.3±1.9%, 1P, 17.5±3.5%, 2P, 72.2±4.7%, 11 samples). Total phosphorylation was 1.62±0.06 molsPi/mol TnI. In myofibrils from end‐stage failing hearts, the unphosphorylated cTnI species predominated (0P was 78.5±1.8%, 1P, 17.5±1.9%, 2P, 4.0±0.7%, total phosphorylation 0.26±0.02 molsPi/mol TnI, five samples). Muscle from patients with hypertrophic obstructive cardiomyopathy was also largely unphosphorylated (0P was 76.6±3.1%, 1P, 17.5±2.7%, 2P, 5.9±0.8%, total phosphorylation 0.29±0.04 molsPi/mol TnI, 19 samples). Using a range of phospho‐specific antibodies we demonstrated that 3/4 of the bis‐phosphorylated band of donor heart cTnI is phosphorylated at Ser22 and Ser23 in approximately equal amounts and that phosphorylation of Ser43 and Thr142 was not detected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decrease in cTnI phosphorylation at Ser22/23 observed in this study (Figs. 2 A, C, and E) is consistent with previous reports which investigated HCM (59, 61, 62).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [59]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · cited 2×
“Discontinuous SDS-PAGE gels (Laemmli) [23] were handcast and run using the Mini-PROTEAN system (Bio-Rad).”
MethodLounging in a lysosome: the intracellular lifestyle of Coxiella burnetii
Voth, D. E., & Heinzen, R. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00901.x · Cited by 11,767
Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins
Kinoshita, E., Kinoshita-Kikuta, E., Takiyama, K., & Koike, T. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500024-mcp200 · Cited by 1,101 · cited 4×
“Gel compositions are as follows: stacking gel: 4% acrylamide (29:1 acrylamide:bis-acrylamide), resolving gel: 10% acrylamide (29:1 acrylamide:bis-acrylamide), 50mM Mn-Phos-tag TM - Acrylamide (NARD Institute, Hyogo, Japan) [18, 19].”
BackgroundInfluentialBowling, N., Walsh, R. A., Song, G., Estridge, T., Sandusky, G. E., Fouts, R. L., Mintze, K., Pickard, T., Roden, R., Bristow, M. R., et al. (1999) · Circulation · doi:10.1161/01.cir.99.3.384 · Cited by 457
In vivo regulation of Yorkie phosphorylation and localization
Oh, H., & Irvine, K. D. (2008) · Development · doi:10.1242/dev.015255 · Cited by 404 · cited 1×
“The method has been validated using pure proteins and has been applied to specific phosphoproteins in complex mixtures using Western blotting with specific antibodies [20–22].”
MethodRegulation of cardiac contractile function by troponin I phosphorylation
LAYLAND, J., SOLARO, R., & SHAH, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.022 · Cited by 385 · cited 4×
“Serines 22 and 23 (23 and 24 in the translated human cDNA sequence) are well established as the main sites in hcTnI phosphorylated by PKA [2, 32, 33].”
BackgroundInfluentialTroponin and Tropomyosin: Proteins That Switch on and Tune in the Activity of Cardiac Myofilaments
Solaro, R. J., & Rarick, H. M. (1998) · Circulation Research · doi:10.1161/01.res.83.5.471 · Cited by 359 · cited 1×
“Serines 22 and 23 (23 and 24 in the translated human cDNA sequence) are well established as the main sites in hcTnI phosphorylated by PKA [2, 32, 33].”
BackgroundVANDERVELDEN, J., PAPP, Z., ZAREMBA, R., BOONTJE, N., DEJONG, J., OWEN, V, BURTON, P., GOLDMANN, P., JAQUET, K., & STIENEN, G. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00606-5 · Cited by 301 · cited 5×
“Since we and others have observed that cTnT is constitutively phosphorylated [4, 5, 17] we dephosphorylated myofibrils with PP1a and PP2a (Fig.”
BackgroundMethodInfluentialIncreased Expression of Cardiac Phosphatases in Patients with End-stage Heart Failure
Neumann, J., Eschenhagen, T., Jones, L. R., Linck, B., Schmitz, W., Scholz, H., & Zimmermann, N. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0271 · Cited by 263 · cited 1×
“On the other hand, non-specific reduction in phosphorylation is compatible with reports of increased phosphatase activity in failing heart, which may itself be a consequence of enhanced PKC activity [4, 41–44].”
BackgroundTroponin I Phosphorylation in the Normal and Failing Adult Human Heart
Bodor, G. S., Oakeley, A. E., Allen, P. D., Crimmins, D. L., Ladenson, J. H., & Anderson, P. A. W. (1997) · Circulation · doi:10.1161/01.cir.96.5.1495 · Cited by 225 · cited 1×
“02 molsPi/mol hcTnI is similar to our previous measurements using the Pro-Q Diamond gel staining technique; indeed most studies have found phosphorylation levels to be very low in end-stage heart failure [4–6, 39].”
Method
Research works printed but not linked: 2
- Jacques A. M., 2007, A comparison between TnT, TnI, MyBP‐C and MLC‐2 phosphorylation in tissue from septal myectomies of hypertrophic obstructive cardiomyopathy patients and donor hearts. Biophysical Society Meeting Abstracts, Biophys. J., S541A
- Messer A. E., 2007, Measurement of troponin phosphatase activities in normal and failing human heart muscle. Biophysical Society Meeting Abstracts, Biophys. J., S630A
Cited by
Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle
Copeland, O., Sadayappan, S., Messer, A. E., Steinen, G. J. M., van der Velden, J., & Marston, S. B. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.007 · Cited by 146
“These resultsfit anemergingpattern of reduced phosphorylation of the myofibrillar targets of PKA observed in pathologies that include failing heart, hypertrophic obstructive cardiomyopathy (in the interventricular septum but not necessarily the rest of the heart) and in atrial fibrillation [18,20,21,24,34,35].”
InfluentialSelf-citationHow Do Mutations in Contractile Proteins Cause the Primary Familial Cardiomyopathies?
Marston, S. B. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9266-2 · Cited by 126
“Troponin I is usually highly phosphorylated in human troponin (approximately 1.1 mol Pi/mol TnI at Ser22 and 23, the PKA sites [ 57 ]), whereas the recombinant proteins previously studied were not phosphorylated.”
BackgroundInfluentialSelf-citationvan Dijk, S. J., Paalberends, E. R., Najafi, A., Michels, M., Sadayappan, S., Carrier, L., Boontje, N. M., Kuster, D. W. D., van Slegtenhorst, M., Dooijes, D., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963702 · Cited by 124
Ackermann, M. A., Kerr, J. P., King, B., Ward, C. W., & Kontrogianni‐Konstantopoulos, A. (2018) · Scientific Reports · doi:10.1038/srep46969 · Cited by 116
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
“2 A, C, and E) is consistent with previous reports which investigated HCM (59, 61, 62).”
ResultSelf-citationAugmented Phosphorylation of Cardiac Troponin I in Hypertensive Heart Failure
Dong, X., Sumandea, C. A., Chen, Y.-C., Garcia-Cazarin, M. L., Zhang, J., Balke, C. W., Sumandea, M. P., & Ge, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.293258 · Cited by 99
Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle
Vikhorev, P. G., & Vikhoreva, N. N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082234 · Cited by 93
Song, W., Dyer, E., Stuckey, D. J., Copeland, O., Leung, M.-C., Bayliss, C., Messer, A., Wilkinson, R., Tremoleda, J. L., Schneider, M. D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252320 · Cited by 68
Self-citationBottenus, D., Jubery, T. Z., Ouyang, Y., Dong, W., Dutta, P., & Ivory, C. F. (2011) · Lab on a Chip · doi:10.1039/c0lc00490a · Cited by 80
Memo, M., Leung, M. C., Ward, D. G., dos Remedios, C. G., Morimoto, S., Zhang, L., Ravenscroft, G., McNamara, E. L., Nowak, K. J., Marston, S. B., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt071 · Cited by 70
“EC50 was measured by the in vitro motility assay and bis-phosphorylation of troponin I (approximates to phosphorylation at Ser22 and 23) was measured by phosphate affinity SDS– PAGE.”
MethodSelf-citationBos, J. M., Hebl, V. B., Oberg, A. L., Sun, Z., Herman, D. S., Teekakirikul, P., Seidman, J. G., Seidman, C. E., dos Remedios, C. G., Maleszewski, J. J., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.028 · Cited by 66
“Age, myectomy (y), median (IQR) 38 (30-53) 43 (16-52) 57 (44-67) .”
BackgroundInfluentialMesser, A. E., & Marston, S. B. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00315 · Cited by 64
“By manipulating the level of Tn phosphorylation and then measuring the level using phosphate affinity SDS-PAGE (Phos-Tags) (Messer et al., 2009), a consistent relationship between phosphorylation level and Ca2+-sensitivity was found (Memo et al., 2013) (Figure 2B).”
BackgroundMethodInfluentialSelf-citationAdvances in Phos-tag-based methodologies for separation and detection of the phosphoproteome
Kinoshita, E., Kinoshita‐Kikuta, E., & Koike, T. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.10.004 · Cited by 64
“As practical examples on human heart failure and hypertrophic cardiomyopathy, quantitative analyses of phosphorylated species of cardiac troponin I were performed by using Mn–Phos-tag SDS-PAGE [32,33].”
MethodInvestigation of a transgenic mouse model of familial dilated cardiomyopathy
Song, W., Dyer, E., Stuckey, D. J., Leung, M. C., Memo, M., Mansfield, C. A., Ferenczi, M. A., Liu, K., Redwood, C. S., Nowak, K., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.05.009 · Cited by 63
Self-citationVikhorev, P. G., Smoktunowicz, N. K., Munster, A. B., Copeland, O., Sawa Kostin, D., Montgiraud, C., Messer, A. E., Toliat, M. R., Li, A. S., dos Remedios, C. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13675-8 · Cited by 61
Self-citationMesser, A. E., Bayliss, C. R., El-Mezgueldi, M., Redwood, C. S., Ward, D. G., Leung, M.-C., Papadaki, M., dos Remedios, C., & Marston, S. B. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.03.027 · Cited by 60
Self-citationWijnker, P. J. M., Sequeira, V., Foster, D. B., Li, Y., dos Remedios, C. G., Murphy, A. M., Stienen, G. J. M., & van der Velden, J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00580.2013 · Cited by 53
Wijnker, P. J. M., Foster, D. B., Tsao, A. L., Frazier, A. H., dos Remedios, C. G., Murphy, A. M., Stienen, G. J. M., & van der Velden, J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00498.2012 · Cited by 50
Nollet, E. E., Westenbrink, B. D., de Boer, R. A., Kuster, D. W. D., & van der Velden, J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018641 · Cited by 45
Bottenus, D., Jubery, T. Z., Dutta, P., & Ivory, C. F. (2011) · Electrophoresis · doi:10.1002/elps.201000510 · Cited by 44
Wang, Y., Pinto, J. R., Solis, R. S., Dweck, D., Liang, J., Diaz-Perez, Z., Ge, Y., Walker, J. W., & Potter, J. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294306 · Cited by 44
Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
Dorsch, L. M., Schuldt, M., dos Remedios, C. G., Schinkel, A. F. L., de Jong, P. L., Michels, M., Kuster, D. W. D., Brundel, B. J. J. M., & van der Velden, J. (2019) · Cells · doi:10.3390/cells8070741 · Cited by 43
Hamdani, N., Borbély, A., Veenstra, S., Kooij, V., Vrydag, W., Zaremba, R., dos Remedios, C. G., Niessen, H. W. M., Michel, M. C., Paulus, W. J., et al. (2010) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-010-9231-8 · Cited by 42
“…reduced PKA-mediated phosphorylation of downstream myofilament target proteins, cardiac myosin binding protein C (cMyBP-C) and troponin I (cTnI) (El-Armouche et al. 2007; van der Velden et al. 2003; Messer et al. 2007, 2009; Copeland et al. 2010), which coincided with increased myofilament Ca 2 ?”
InfluentialVikhorev, P. G., Vikhoreva, N. N., Yeung, W., Li, A. S., Lal, S., dos Remedios, C. G., Blair, C. A., Guglin, M. E., Campbell, K. S., Yacoub, M. H., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa316 · Cited by 41
“107 (referred as FA, FC, and FD) have been reported earlier.(57) Statistical analysis was performed using one-way ANOVA with Fisher’s least significant difference test.”
MethodSelf-citationTroponin I phosphorylation in human myocardium in health and disease
Wijnker, P. J. M., Murphy, A. M., Stienen, G. J. M., & van der Velden, J. (2014) · Netherlands Heart Journal · doi:10.1007/s12471-014-0590-4 · Cited by 41
“However, a recent study in patients with obstructive hypertrophic cardiomyopathy (HCM) and normal systolic, but impaired diastolic function (NYHA class III) showed increased myofilament Ca sensitivity [26] and lower cTnI phosphorylation [27, 28] in HCM compared with non-failing myocardium.”
BackgroundGarrido, A. M., Biesiadecki, B. J., Salhi, H. E., Shaifta, Y., dos Remedios, C. G., Ayaz‐Güner, Ş., Cai, W., Ge, Y., Avkiran, M., & Kentish, J. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001292 · Cited by 40
“Use of a phospho-Ser24-specific antibody (17) helped to identify the major target site for PKD in cTnI (Fig.”
BackgroundMethodInfluentialPapadaki, M., Vikhorev, P. G., Marston, S. B., & Messer, A. E. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv181 · Cited by 39
Self-citationBottenus, D., Hossan, M. R., Ouyang, Y., Dong, W., Dutta, P., & Ivory, C. F. (2011) · Lab on a Chip · doi:10.1039/c1lc20469f · Cited by 37
The continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform
Soetkamp, D., Raedschelders, K., Mastali, M., Sobhani, K., Bairey Merz, C. N., & Van Eyk, J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1387054 · Cited by 36
“Thus, HCM with normal systolic but impaired diastolic function (New York Heart Association class III) is associated with decreased S23/24 cTnI phosphorylation [64,98,99] and increased myofilament Ca sensitivity [100].”
Bayliss, C. R., Jacques, A. M., Leung, M.-C., Ward, D. G., Redwood, C. S., Gallon, C. E., Copeland, O., McKenna, W. J., dos Remedios, C., Marston, S. B., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvs322 · Cited by 34
“Isometric force is reduced(7) and in myocytes, amplitude and rates of contraction and relaxation are reduced(8); there is increased expression of the skeletal isoform of actin(21) and low levels of MyBP-C and TnI phosphorylation.(22,23) Functional investigation of the individual contractile proteins showed that cardia…”
InfluentialSelf-citationSevrieva, I. R., Brandmeier, B., Ponnam, S., Gautel, M., Irving, M., Campbell, K. S., Sun, Y., & Kampourakis, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011945 · Cited by 32
“7 before serine 22 (32,33), further suggesting that cMLCK phosphorylation of serine 23 might prime serine 22 for phosphorylation by PKA and other kinases.”
BackgroundVikhorev, P. G., Song, W., Wilkinson, R., Copeland, O., Messer, A. E., Ferenczi, M. A., & Marston, S. B. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.10.024 · Cited by 28
“Ser-22/23) in common with previous measurements (22,24).”
BackgroundSelf-citationAckermann, M. A., Ward, C. W., Gurnett, C. A., & Kontrogianni‐Konstantopoulos, A. (2015) · Scientific Reports · doi:10.1038/srep13235 · Cited by 27
McKee, L. A. K., Chen, H., Regan, J. A., Behunin, S. M., Walker, J. W., Walker, J. S., & Konhilas, J. P. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.12.023 · Cited by 27
Messer, A. E., Chan, J., Daley, A., Copeland, O., Marston, S. B., & Connolly, D. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00348 · Cited by 27
“The overall phosphorylation of the nonHCM cat samples was 3.03 ± 0.37 mols Pi/mol (n = 4), which compares with 2.70 ± 0.07 mols Pi/mol reported in human FIGURE 2 | SDS-PAGE of cat and human myofibrillar fraction.”
BackgroundMethodSelf-citationA Revised Perspective on the Evolution of Troponin I and Troponin T Gene Families in Vertebrates
Joyce, W., Ripley, D. M., Gillis, T. E., Black, A. C., Shiels, H. A., & Hoffmann, F. G. (2022) · Genome Biology and Evolution · doi:10.1093/gbe/evac173 · Cited by 26
Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy
Ušaj, M., Moretto, L., & Månsson, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042195 · Cited by 25
“A confounding factor related to the mutation effects on calcium sensitivity in myofibrils and skinned fibers from patients is that they are often reversed if the reduced TnI phosphorylation levels [193] are restored to normal by treatment with protein kinase A [171].”
BackgroundTropomyosin isoform expression and phosphorylation in the human heart in health and disease
Marston, S. B., Copeland, O., Messer, A. E., MacNamara, E., Nowak, K., Zampronio, C. G., & Ward, D. G. (2013) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-013-9347-8 · Cited by 24
“The location close to the end of the polypeptide probably explains our inability to detect phosphorylation using Pro-Q Diamond or Phosphate Affinity SDS-PAGE; TnT phosphorylation at Ser1 could also not be detected in Phosphate Affinity SDS-PAGE (Messer et al. 2009).”
BackgroundMethodResultInfluentialSelf-citationSheehan, A., Messer, A. E., Papadaki, M., Choudhry, A., Křen, V., Biedermann, D., Blagg, B. S. J., Khandelwal, A., & Marston, S. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00243 · Cited by 22
“The level of TnI phosphorylation was measured by phosphate affinity SDS–PAGE as previously described (Messer et al., 2009).”
MethodSelf-citationQiu, W., & Steinberg, S. F. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.08.005 · Cited by 21
Ackermann, M. A., Kerr, J. P., King, B., Ward, C. W., & Kontrogianni‐Konstantopoulos, A. (2015) · Scientific Reports · doi:10.1038/srep12637 · Cited by 20
Sevrieva, I. R., Ponnam, S., Yan, Z., Irving, M., Kampourakis, T., & Sun, Y. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102767 · Cited by 19
“This led to some misidentification of the phospho-species (40, 41).”
BackgroundKinoshita, E., Kinoshita‐Kikuta, E., Yamada, A., Inoue, C., & Koike, T. (2011) · Journal of Integrated OMICS · doi:10.5584/jiomics.v1i1.46 · Cited by 19
Leung, M. C., Hitchen, P. G., Ward, D. G., Messer, A. E., & Marston, S. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410316 · Cited by 17
Self-citationNeutral Phosphate-Affinity SDS-PAGE System for Profiling of Protein Phosphorylation
Kinoshita‐Kikuta, E., Kinoshita, E., & Koike, T. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2550-6_24 · Cited by 17
Kopylova, G. V., Nabiev, S. R., Nikitina, L. V., Shchepkin, D. V., & Bershitsky, S. Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.013 · Cited by 16
Wijnker, P. J. M., Sequeira, V., Witjas‐Paalberends, E. R., Foster, D. B., dos Remedios, C. G., Murphy, A. M., Stienen, G. J. M., & van der Velden, J. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.017 · Cited by 16
LKB1/Mo25/STRAD Uniquely Impacts Sarcomeric Contractile Function and Posttranslational Modification
Behunin, S. M., Lopez‐Pier, M. A., Birch, C. L., McKee, L. A. K., Danilo, C., Khalpey, Z. I., & Konhilas, J. P. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.02.012 · Cited by 15
“In this study, therefore, we cannot rule out the existence of other phosphospecies as indicated in previous work (25).”
ResultIonic liquid‐assisted SDS‐PAGE to improve human serum protein separation
Zhang, T., Gai, Q., Qu, F., & Zhang, Y. (2011) · Electrophoresis · doi:10.1002/elps.201100184 · Cited by 12
Karam, C. N., Warren, C. M., Henze, M., Banke, N. H., Lewandowski, E. D., & Solaro, R. J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00469.2016 · Cited by 10
Mn2+‐Phos‐Tag Polyacrylamide for the Quantification of Protein Phosphorylation Levels
Markandran, K., Xuan, J. V. L. E., Yu, H., Shun, L. M., & Ferenczi, M. A. (2021) · Current Protocols · doi:10.1002/cpz1.221 · Cited by 10
Myosin from the ventricle is more sensitive to omecamtiv mecarbil than myosin from the atrium
Shchepkin, D. V., Nabiev, S. R., Nikitina, L. V., Kochurova, A. M., Berg, V. Y., Bershitsky, S. Y., & Kopylova, G. V. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.108 · Cited by 10
Toepfer, C. N., Sikkel, M. B., Caorsi, V., Vydyanath, A., Torre, I., Copeland, O., Lyon, A. R., Marston, S. B., Luther, P. K., MacLeod, K. T., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00899.2015 · Cited by 9
Self-citationKhokhlova, A., Myachina, T. A., Butova, X., Kochurova, A. M., Polyakova, E. A., Galagudza, M. M., Solovyova, O. E., Kopylova, G. V., & Shchepkin, D. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158356 · Cited by 4
Copeland, O., Messer, A., Jabbour, A., Poggesi, C., Prasad, S., & Marston, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00241 · Cited by 3
“…13 heart muscle biopsies from intraventricular septum and free wall taken from patients undergoing valve surgery to relieve pressure overload and compared them with previously studied donor heart samples and myectomy samples from patients with HOCM (Messer et al., 2009; Copeland et al., 2010).”
BackgroundMethodResultInfluentialSelf-citationBarry, M. E., Rynkiewicz, M. J., Jian, W., Tu, A.-Y., Regnier, M., Lehman, W., & Moore, J. R. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110380 · Cited by 3
The Molecular Foundations of High Heart Rates: Sarcomeric Protein Adaptations
Joyce, W. (2025) · Physiology · doi:10.1152/physiol.00021.2025 · Cited by 2
Multiphysics model of a rat ventricular myocyte: A voltage-clamp study
Krishna, A., Valderrábano, M., Palade, P., & John, W. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-48 · Cited by 2
“Modulation of myofilament Ca2+ sensitivity (MCS) as a result of a change in Troponin I (TnI) phosphorylation by PKA has been implicated in heart failure [45].”
BackgroundDonor hearts in the Sydney Heart Bank: reliable control but is it ‘normal’ heart?
Marston, S. B., Jacques, A. M., Bayliss, C. R., Dyer, E., Memo, M., Papadaki, M., & Messer, A. E. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00740-2 · Cited by 2
Self-citationAltered contractile mechanics and Ca2+ handling contribute to cardiomyopathy pathogenesis
Turtle, C. W. (2015) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-8gvydxm1r · Cited by 1
LIMK1 regulates centrosome integrity and mitotic spindle positioning
Ou, S. (2015) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/65350
“144 phosphorylation status and profile of endogenous proteins (Messer et al., 2009).”
BackgroundDEVELOPMENT OF MICROCHIP ISOTACHOPHORESIS FOR THE DETECTION OF NOVEL CARDIAC TROPONIN I BIOMARKERS
Jacroux, T. J. (2016) · Research Exchange (Washington State University)
Behunin, S. M. (2015) · UA Campus Repository (The University of Arizona)
Optimized Mn²⁺–Phos-tag Gels Reveal Sarcomeric Protein Dephosphorylation upon Myofibril PreparationPreprint
Syed, S. B., Fenwick, A. J., Bodt, S. M. L., Wishard, R., & Foster, D. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.21.746362
Metadata
- Authors
- Messer, A. E., Gallon, C. E., McKenna, W. J., Dos Remedios, C. G., & Marston, S. B.
- Affiliations
- Imperial College London (GB)
- University College London (GB)
- Corresponding author
- Messer, Andrew E.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2009-12
- Volume
- 3
- Issue
- 12
- Pages
- 1371-1382
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2020563127
- Cited by
- 61
- References
- 49
- Citations by year
- 2025: 2 · 2022: 4 · 2021: 1 · 2020: 8 · 2019: 1 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 6 · 2013: 3 · 2012: 4
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PROTEOMICS - CLINICAL APPLICATIONS (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation grant (PG/08/077/25587, RG/02010, PG/06/027/20425)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- cardiac troponin I, protein kinase A, heart failure, hypertrophic obstructive cardiomyopathy, myofibrils
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.